应用韩氏穴位神经刺激仪HANS经皮治疗周围性面瘫效果观察

目的：观察韩氏穴位神经刺激仪（Han’Sacupoint nerve stimulator,HANS）经皮治疗周围性面瘫的效果。方法：将61例周围性面瘫患者随机分为两组,HANS组31例（选用4对穴位,每天刺激1次）。对照组30例采用普通针刺手法。取穴相同,连续治疗20天。结果：HANS组痊愈21例,对照组痊愈11例,两组痊愈率的差异有统计学意义（P〈0.05）。结论：经穴位神经刺激仪治疗周围性面瘫,痊愈率高于对照组。     

经颅交变磁场治疗周围性面瘫的疗效观察

目的:探讨经颅交变磁场治疗周围性面瘫的临床疗效。方法:70例周围性面瘫患者分为治疗组(40例)和对照组(30例),治疗组用经颅交变磁场结合药物治疗,对照组用针刺结合药物治疗,两个疗程后观察两组的临床疗效。结果:治疗组痊愈率72.5%,对照组痊愈率76.6%;两组痊愈率之间差异无显著性(P>0.05);治疗组总有效率90.0%,对照组93.3%,两组总有效率之间差异亦无显著性(P>0.05)。结论经颅交变磁场对治疗周围性面瘫有较好的疗效,值得临床推广。     

精穴疏针法治疗周围性面瘫临床观察

目的：观察精穴疏针法治疗周围性面瘫的临床疗效。方法：60例周围性面瘫患者分为2组,每组各30例,观察两组治疗前后病情变化,并对结果进行统计学分析。结果：治疗组总有效率1013％,痊愈率80．7％;对照组总有效率96．7％,痊愈率66．7％,两组疗效比较无显著性差异,P〉0．05。结论：精穴疏针法与常规针刺法疗效无明显差异,且在痊愈患者的治疗天数上少于常规针刺法。     

针刺翳风穴结合推拿治疗周围性面瘫74例

目的：探讨针刺翳风穴结合推拿治疗周围性面瘫的疗效.方法：采用针刺翳风穴结合推拿治疗74例周围性面瘫,与24例单纯采用推拿治疗周围性面瘫疗效相比较.结果：治疗组总有效率为98.7%,对照组总有效率为83.3%.两组比较,差异有显著性（P＜0.01）.结论：针刺翳风穴结合推拿法治疗周围性面瘫优于单纯推拿疗法.     

针刺分期辨证治疗周围性面瘫的临床价值分析

目的:探析分期辩证针刺治疗周围性面瘫的临床效果及应用价值。方法:本研究随机抽取我院针灸门诊收治的120例周围性面瘫患者为研究对象,采用随机数字法分为2组,对照组60例患者采用常规针刺疗法,治疗组60例患者采用分期辩证针刺治疗,观察两组患者治疗4周后疗效,对比分析两组患者面神经麻痹程度分级评分和House-Brackmann评分改善情况。结果:观察组患者治疗4周后痊愈率88.33%、总有效率100.00%明显高于对照组36.67%、78.33%(P0.05);两组患者面神经麻痹程度分级评分、House-Brackmann评分、FDI量表评分治疗前比较差异不显著(P0.05),治疗后观察组患者各项评分改善情况明显优于对照组(P0.05)。结论:临床上采用分期针刺治疗周围性面瘫疗效明显优于常规针刺治疗,早期治疗效果更为显著,值得广泛推广和应用。     

温针灸分期治疗埃塞俄比亚黑人周围性面瘫临床研究

目的：探讨温针灸分期治疗埃塞俄比亚黑人周围性面瘫的临床疗效。方法：将278例埃塞俄比亚黑人周围性面瘫患者随机分为对照组和治疗组。治疗组148例按病程分为急性期、静止期和恢复期三期,不同时期施以温针灸为主的不同针刺方法,取穴以手足阳明经穴为主,手足少阳经穴为辅。对照组130例采用常规针灸治疗,穴取合谷、风池、下关、翳风、颊车、地仓、迎香等。从愈显率和治疗时间评价两组治疗效果。结果：治疗4个疗程后,治疗组愈显率为86.62%,优于对照组的60.77%（P<0.05）。在前3个疗程内,治疗组痊愈率为89.79%,优于对照组的56.86%（P<0.05）。治疗组痊愈患者的疗程较对照组明显缩短（ P<0.05）。结论：温针灸分期治疗埃塞俄比亚黑人周围性面瘫有较好疗效。     

针刺结合全程艾灸治疗风寒型周围性面瘫临床疗效观察30例

目的观察针刺结合全程艾灸治疗风寒型周围性面瘫的临床疗效。方法选取60例风寒型周围性面瘫患者,按1:1的比例将患者分为治疗组30例、对照组30例。治疗组采用发病一周后针刺结合全程艾灸的方法,针刺15次后观察疗效;对照组采用针刺治疗,针刺穴位、方法及疗程同治疗组。结果治疗组治愈26例,显效2例,愈显率为93.33%;对照组治愈21例,显效3例,愈显率为80%。两组对比,治疗组疗效显著(P0.01),且明显优于对照组。结论针刺结合全程艾灸治疗风寒型周围性面瘫疗效确切。     

割治疗法结合针刺治疗周围性面瘫的疗效观察

目的探寻周围性面瘫的最佳治疗方案。方法将120例患者随机分为治疗组（割治＋针刺）与对照组（针刺＋超短波）,经3个疗程治疗后进行疗效对比观察。结果两组有效率分别为92%和80%,治疗组与对照组的痊愈率相比有明显差异（P〈0.05）,治疗组与对照组在治疗的疗程上相比有显著差异（P〈0.01）。结论割治疗法结合针刺治疗周围性面瘫可以明显提高痊愈率,是治疗本病的最佳方案。     

庄礼兴教授针灸中药并用治疗小儿周围性面瘫经验缬要

[目的]介绍及总结庄礼兴教授以针灸中药并用治疗小儿周围性面瘫的经验。[方法]通过文献研究方法,整理庄礼兴教授的病案,简述小儿周围性面瘫的研究现状,从选穴、刺法、灸法及用药等方面对庄礼兴教授治疗小儿周围性面瘫的经验进行总结,并举两则验案予以佐证。[结果]庄礼兴教授治疗小儿周围性面瘫,针刺取穴以靳三针为主,配合远端取穴,并运用半刺、毛刺之法,且尤其重视灸法的运用,独取督脉施灸。中药方面,强调分期论治,急性期重在祛风散寒,恢复期则益气通络。本文两例验案中,患儿均为突发性口角歪斜,案一辨证为风寒阻络证,治以祛风散寒、解痉通络,以针灸配合牵正散内服,案二辨证为风寒证,治以祛风散寒、解痉通络,以针灸配合牵正散内服,两例患者均取得良好疗效。[结论]庄礼兴教授遵循靳三针法取穴,以半刺、毛刺为法,配合督脉施灸和中药内服,治疗小儿周围性面瘫,疗效显著,值得临床学习借鉴。     

磁极针治疗恢复期周围性面瘫66例临床疗效分析

目的:寻找对恢复期周围性面瘫有效的治疗方法。方法:采用磁极针针刺治疗恢复期周围性面瘫66例(治疗组),并与普通毫针针刺治疗恢复期周围性面瘫62例(对照组)作比较,判断分析结果。结果:治疗组痊愈36例(占54.5%),显效17例(占25.8%),有效9例(占13.6%),无效4例(占6.1%);对照组痊愈17例(占27.4%),显效14例(占22.6%),有效21例(占33.9%),无效10例(占16.1%)。治疗组与对照组之间的疗效差异有显著性意义(P<0.05)。结论:表明采用磁极针针刺治疗的治疗组疗效优于采用普通毫针针刺治疗的对照组。     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

Dr.Zhang Ren''''s Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

Luo Lingjie''''s Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.     

猪肺磷脂注射液联合经鼻持续气道正压通气对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性的影响

目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P＜0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P＜0.05),PaCO2均随观察时间的延长而降低(P＜0.05).观察组治疗有效率为87.5％,显著高于对照组的70.0％ (P ＜0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P＜0.05),且观察组明显低于对照组(P＜0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.     

Survey and practice of reporting quality of randomized controlled clinical trials on traditional Chinese medicine

Evidence obtained from randomized controlled trials （RCTs） has been generally accepted as the gold standard in the evaluation of clinical effectiveness. Readers need to understand the trial design, implementation, results, analysis and interpretation, so as to fully Jnderstand the results of RCTs. Thus, the investigators of RCTs have to report these items in a complete, accurate and clear manner. Since 1998, we have conducted several evaluations on the reporting quality of RCTs published in Chinese journals on traditional Chinese medicine （TCM） and results have shown that there is an urgent need for higher quality RCTs on TCM.     

TCM Treatment of Ankylosing Spondylitis by Tonifying the Kidney and Strengthening the Governor Vessel

Ankylosing spondylitis is a chronic and progressive disorder with inflammation mainly involving the central axis joints. It mainly affects the cervical spine and the lumbosacral area, with the pathogenesis closely related to the kidney and the Governor Vessel (GV). TCM holds that the syndrome is deficiency in origin and excess in superficiality, which is due to insufficiency of the kidney, deficiency of GV, and blocking of the channels with the invasion of exogenous evil, leading to poor circulation of qi and blood and malnutrition of the bones, muscles and joints. The TCM method of tonifying the kidney and strengthening GV to regulate circulation of qi and blood and check the arthralgia pain should be adopted, with the Kidney-Tonifying and GV Strengthening Decoction (益肾强督汤) prescribed.     

IMPROVING P-gp EXPRESSION IN HUMAN MONONUCLEAR CELLS IN VITRO TRANSFECTED BY MULTIDRUG RESISTANCE-1 mRNA

CHEMOTHERAPY playsa greatrolein the treat- ment of malignanttumors,especiallyingynecolo- gicalones.But inanticancerchemotherapy,leuko-cytopeniaisfrequentlytheprimarydose-limitingsideeffect factor.Moreover,cancersarefrequentlychemoresistantbe-causeof overexpressionof P-glycoprotein(P-gp), which isencodedby multidrugresistancegene (MDR1 ) and detectableinup to50% ofhuman cancersand renderscellsresistancetoanticancerdrugs.The safetyand potentialtherapeuticbenefitof mdr1 gene transferredto h…